Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AramarkARMK · Entity 3359 | Director | September 09, 2026 | September 10, 2026 |
| TAPESTRY, INC.TPR · Entity 2309 | Chief Financial Officer | August 16, 2018 | August 20, 2018 |
| TIVITY HEALTH, INC.TVTY · Entity 125776 | Director | February 26, 2020 | February 28, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aramark
Report date September 09, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,974.546 |
Reported balance
After 2026-09-09 transaction · row 1
1 source rowRow 1 · 2026-09-09 · Grant · Acquired 34.551 · Balance 21,974.546 F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
TAPESTRY, INC.
Report date August 16, 2018 · Filed August 20, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,565 |
Reported balance
After 2018-08-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-08-16 · Grant · Acquired 7,007 · Balance 100,565 F1: These securities were acquired in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest in four equal tranches on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 16, 2019, the second on August 16, 2020, the third on August 16, 2021 and the fourth on August 16, 2022. |
| Common StockSEC Table I · non-derivative | Direct | 99,628 |
Reported balance
After 2018-08-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-08-17 · Tax withholding · Disposed 937 · Balance 99,628 F2: These shares were withheld to pay for the taxes in connection with the vesting of the restricted stock units on the Transaction Date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $51.38 · Expires 2028-08-16 | Direct | 62,350 |
Reported balance
After 2018-08-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-08-16 · Grant · Acquired 62,350 · Balance 62,350 F3: These securities were issued under the Issuer's Stock Incentive Plan. F4: These securities will convert on a 1-for-1 basis into shares of the issuer's common stock. F5: These service-based securities vest in four equal installments on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 16, 2019, the second on August 16, 2020, the third on August 16, 2021 and the fourth on August 16, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities were acquired in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest in four equal tranches on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 16, 2019, the second on August 16, 2020, the third on August 16, 2021 and the fourth on August 16, 2022.
F2: These shares were withheld to pay for the taxes in connection with the vesting of the restricted stock units on the Transaction Date.
F3: These securities were issued under the Issuer's Stock Incentive Plan.
F4: These securities will convert on a 1-for-1 basis into shares of the issuer's common stock.
F5: These service-based securities vest in four equal installments on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 16, 2019, the second on August 16, 2020, the third on August 16, 2021 and the fourth on August 16, 2022.
TIVITY HEALTH, INC.
Report date February 26, 2020 · Filed February 28, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,143 |
Reported balance
After 2020-02-26 transaction · row 1
1 source rowRow 1 · 2020-02-26 · Purchase · Acquired 20,000 · Balance 53,143 F1: This transaction was executed in multiple trades at prices ranging from $12.00 to $12.17, inclusive. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $12.00 to $12.17, inclusive. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 10, 2026 20:13 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 34.551 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-26-000125 · wk-form4_1789071226.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,974.546 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:29 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 36.644 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-26-000108 · wk-form4_1780612166.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,939.995 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:42 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 47.619 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-26-000076 · wk-form4_1772746958.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,903.351 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 03, 2026 Filed Feb 4, 2026 21:34 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 5,124 | $38.06 | $195,019.44 |
DisclosureSEC source: 0001584509-26-000027 · wk-form4_1770240843.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,855.732 F1 · shares: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 22:15 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 35.42 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000239 · wk-form4_1766096140.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,731.732 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 20:21 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 29.129 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000183 · wk-form4_1755807704.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,696.312 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 28, 2025 Filed May 29, 2025 20:38 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 29.023 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000145 · wk-form4_1748551092.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,667.183 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 21:09 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 31.223 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000078 · wk-form4_1740517793.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,638.16 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 22:45 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000030 · wk-form4_1738017902.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,606.937 F1 · shares: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:05 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 15.691 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000290 · wk-form4_1734123940.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,606.937 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:08 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 15.759 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000181 · wk-form4_1725566903.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,591.246 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:03 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 17.924 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000132 · wk-form4_1717102606.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,575.487 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:06 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 18.563 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000070 · wk-form4_1709327182.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,557.563 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:25 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 5,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000031 · wk-form4_1706822737.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,539 F1 · shares: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:51 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 0.517 | $29.24 | $15.12 |
DisclosureSEC source: 0001584509-24-000020 · wk-form4_1706737850.xml · nonDerivative · entry 2 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,554 F2 · shares: Represents the rounding up of fractional shares. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:51 UTC | Aramark ARMK · Entity 3359 | Tax withholdingCommon Stock | 36 | $29.24 | $1,052.64 |
DisclosureSEC source: 0001584509-24-000020 · wk-form4_1706737850.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,553.483 F1 · shares: Represents shares withheld to pay taxes applicable to vesting of deferred stock units. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 22:49 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 19.483 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000300 · wk-form4_1702421347.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,589.483 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. F2 · balance_after: Includes an adjustment to the number of deferred stock units held by the Reporting Person in connection with the completion of the separation of the Issuer's uniforms and workplace supplies business on September 30, 2023. Read SEC document |
| August 29, 2023 Filed Aug 31, 2023 00:50 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 11.71 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000182 · wk-form4_1693443045.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,015.474 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:42 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 11.124 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000134 · wf-form4_168573850335993.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,003.764 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:20 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 11.64 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000097 · wf-form4_167848322744348.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,992.64 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:08 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 3,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000046 · wf-form4_167580770314003.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,981 F1 · shares: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:24 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | PurchaseCommon Stock | 20,000 | $12.07 | $241,400.00 |
DisclosureSEC source: 0001567619-20-005130 · doc1.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,143 F1 · shares: This transaction was executed in multiple trades at prices ranging from $12.00 to $12.17, inclusive. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · price: This transaction was executed in multiple trades at prices ranging from $12.00 to $12.17, inclusive. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 23, 2019 Filed May 28, 2019 15:09 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 6,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-012203 · doc1.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,143 F1 · shares: Reflects restricted stock units that vest on the earlier of (i) the first anniversary of the Grant Date (such Grant Date being 5/23/2019), or (ii) the first annual meeting of the stockholders of Tivity Health that occurs after the Grant Date. Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 23:15 UTC | TAPESTRY, INC. TPR · Entity 2309 | Tax withholdingCommon Stock | 937 | $51.41 | $48,171.17 |
DisclosureSEC source: 0001225208-18-012785 · doc4.xml · nonDerivative · entry 2 Wills Kevin · CIK 0001327345 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,628 F2 · security: These shares were withheld to pay for the taxes in connection with the vesting of the restricted stock units on the Transaction Date. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 23:15 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantStock Option · Derivative | 62,350 | $0.00 Strike: $51.38 | $0.00 |
DisclosureSEC source: 0001225208-18-012785 · doc4.xml · derivative · entry 3 Wills Kevin · CIK 0001327345 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,350 Underlying: Common Stock · 62,350 shares Expires 2028-08-16 F3 · security: These securities were issued under the Issuer's Stock Incentive Plan. F4 · derivative.exercise_price: These securities will convert on a 1-for-1 basis into shares of the issuer's common stock. F5 · derivative.exercise_date: These service-based securities vest in four equal installments on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 16, 2019, the second on August 16, 2020, the third on August 16, 2021 and the fourth on August 16, 2022. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 23:15 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantCommon Stock | 7,007 | $51.38 | $360,019.66 |
DisclosureSEC source: 0001225208-18-012785 · doc4.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,565 F1 · security: These securities were acquired in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest in four equal tranches on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 16, 2019, the second on August 16, 2020, the third on August 16, 2021 and the fourth on August 16, 2022. Read SEC document |
| May 24, 2018 Filed May 25, 2018 13:07 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 2,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-025697 · doc1.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,045 F1 · shares: Reflects restricted stock units that vest on the earlier of (i) the first anniversary of the Grant Date (such Grant Date being 5/24/2018), or (ii) the first annual meeting of the stockholders of Tivity Health that occurs after the Grant Date. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 22:19 UTC | TAPESTRY, INC. TPR · Entity 2309 | Tax withholdingCommon Stock | 9,446 | $51.20 | $483,635.20 |
DisclosureSEC source: 0001225208-18-005782 · doc4.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,469 F1 · security: These securities were withheld to pay for the taxes in connection with the vesting of restricted stock units on the Transaction Date. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 22:03 UTC | TAPESTRY, INC. COH · Entity 2309 | GrantStock Option · Derivative | 73,236 | $0.00 Strike: $41.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014184 · doc4.xml · derivative · entry 2 Wills Kevin · CIK 0001327345 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,236 Underlying: Common Stock · 73,236 shares Expires 2027-08-17 F2 · security: These securities were issued under the Amended and Restated Coach, Inc. 2010 Stock Incentive Plan (Amended and Restated as of September 23, 2016) of the Issuer. F3 · derivative.exercise_price: These securities will convert on a 1-for-1 basis into shares of the issuer's common stock. F4 · derivative.exercise_date: These service-based securities vest in four equal installments on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 17, 2018, the second on August 17, 2019, the third on August 17, 2020 and the fourth on August 17, 2021. Read SEC document |
| August 17, 2017 Filed Aug 18, 2017 22:03 UTC | TAPESTRY, INC. COH · Entity 2309 | GrantCommon Stock | 6,829 | $41.00 | $279,989.00 |
DisclosureSEC source: 0001225208-17-014184 · doc4.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,551 F1 · security: These securities were acquired in the form of unvested restricted stock units issued under the Amended and Restated Coach, Inc. 2010 Stock Incentive Plan (Amended and Restated as of September 23, 2016) of the Issuer. These securities will vest in four equal tranches on the first, second, third and fourth anniversaries of the date of grant. The first tranch will vest on August 17, 2018, the second on August 17, 2019, the third on August 17, 2020 and the fourth on August 17, 2021. Read SEC document |
| May 25, 2017 Filed May 30, 2017 11:07 UTC | TIVITY HEALTH, INC. TVTY · Entity 125776 | GrantCommon Stock | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-022654 · doc1.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,169 F1 · shares: Reflects restricted stock units that vest on 5/25/2018. Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 22:20 UTC | TAPESTRY, INC. COH · Entity 2309 | GrantCommon Stock | 92,057 | $38.02 | $3,500,007.14 |
DisclosureSEC source: 0001225208-17-005763 · doc4.xml · nonDerivative · entry 1 Wills Kevin · CIK 0001327345 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,057 F1 · security: All of the securities acquired were received in the form of unvested restricted stock units issued under the Amended and Restated Coach, Inc. 2010 Stock Incentive Plan (Amended and Restated as of September 23, 2016) of the Issuer. These securities will vest in four equal tranches on March 6 of 2018, 2019, 2020, and 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.